Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2011 / Cilt: 8 - Sayı: 3

Comparision of serum high density lipoprotein and sphingosine-1-phosphate levels between hypertensive and normotensive pregnancies

Serum yüksek dansiteli lipoprotein ve sfingozin-1-fosfat düzeylerinin, hipertansif ve normotansif gebelikler arasında karşlaştırılması

Pages
164–168
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no statistically significant difference between groups.Conclusion: We concluded that further studies are needed to evaluate the effects of HDL and associated S1P upon the vascular tonus in hypertensive diseases of pregnancies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare serum high density lipoprotein (HDL) and associated sphingosine-1-phosphate (S1P) levels between hypertensive and normotensive pregnant women and to study likely effect of these parameters on the development of hypertension.Design: A comparative cohort study.
📊
Key Findings & Data:Setting: This prospective study was conducted between December 2008 and March 2009 at department of Obstetrics and Gynecology, Suleyman Demirel University, Isparta.Interventions: Plasma S1P and HDL levels were analyzed.
💡
Conclusion & Impact:There was no statistically significant difference between groups.Conclusion: We concluded that further studies are needed to evaluate the effects of HDL and associated S1P upon the vascular tonus in hypertensive diseases of pregnancies.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To compare serum high density lipoprotein (HDL) and associated sphingosine-1-phosphate (S1P) levels between hypertensive and normotensive pregnant women and to study likely effect of these parameters on the development of hypertension.Design: A comparative cohort study. Setting: This prospective study was conducted between December 2008 and March 2009 at department of Obstetrics and Gynecology, Suleyman Demirel University, Isparta.Interventions: Plasma S1P and HDL levels were analyzed. Material and methods: S1P levels and HDL levels were analyzed by ELISA. Results: Forty normotensive and 40 hypertensive pregnant women was included to the study. Demographical and obstetrical characteristics of patients were similar. SP1 and HDL levels were 0,6±0.32 nM and 61.6±15.3 mg/dl in hypertensive pregnant women. SP1 and HDL levels were 2,1±10.8 nM and 60.2±14.4 mg/dl in normotensive pregnant women. There was no statistically significant difference between groups.Conclusion: We concluded that further studies are needed to evaluate the effects of HDL and associated S1P upon the vascular tonus in hypertensive diseases of pregnancies.

Özet

Amaç: Hipertansif ve normotansif gebe kadınlarda yüksek dansiteli lipoprotein (HDL) ve bununla ilişkili sfingozin (S1P) düzeylerini karşılaştırmak ve bu parametrelerin hipertansiyon gelişimi üzerindeki olası etkilerini araştırmaktır. Planlama: Karşılaştırmalı kohort çalışma. Ortam: Bu prospektif çalışma, aralık 2008 ve mart2009 tarihleri arasında Süleyman Demirel Üniversitesi Tıp Fakültesi Kadın Doğum Kliniğine başvuran hastalarda yapıldı. Girişim: Plazma S1P ve HDL düzeyleri çalışıldı. Gereç ve yöntemler: Hipertansif ve normotansif gebelerde, ELİZA yöntemi ile S1P ve HDL düzeyleri analiz edildi. Sonuç: 40 normotensif ve 40 hipertansif gebe kadın çalışmaya dahil edildi. Demografik ve obstetrik karakteristikler her 2 grupta benzerdi. Hipertansif gebe kadınlarda S1P ve HDL düzeyleri 0,6±0.32 nM ve 61.6±15.3 mg/dl iken normotansif gebe kadınlarda 2,1±10.8 nM ve 60.2±14.4 mg/dl idi. Her 2 grup arasında istatistiksel fark saptanmadı. Yorum: Biz bu çalışmada HDL ve onunla ilişkili S1P’nin gebelikteki hipertansif hastalıklarda vasküler tonus üzerine etkisini değerlendirmek için daha ileri çalışmalara gereksinim olduğu kanaatindeyiz.

🔖

Cite This Article

GÜNYELİ, İ., ERDEMOĞLU, E., ORAL, B., GÜNEY, M., MUNGAN, T., DİLMEN, E., BAYHAN, G. (2022). Comparision of serum high density lipoprotein and sphingosine-1-phosphate levels between hypertensive and normotensive pregnancies. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 8 - Sayı: 3, 164–168. https://ajindex.com/articles/631735

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Gifford RW, August PA, Cunningham G et al. Report of the National High Blood Pressure Education Programme Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: 51- 5
  2. American College of Obstetricians and Gynecologists: Hypertension in Pregnancy. Washington DC, The college; 1996: 219- 23
  3. National High Blood Pressure Education Working Group: High blood pressure during pregnancy. Am J Obstet Gynecol 1990; 163: 1689- 712
  4. Robinson NJ, Minchell LJ, Myers JE, Hubel CA, Crocker IP. A potential role for free fatty acids in the pathogenesis of preeclampsia. J Hypertens 2009; 27: 1293- 302
  5. Goode GK, Miller JP, Heagerty AM. Hyperlipidemia, hypertension and coronary hearth disease. Lancet 1995; 345: 362- 5
  6. Nofer JR, Van der Giet M, Tolle M, Wolinska I, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 2004; 113: 569- 81
  7. Yatomi Y, Ruan F, Hakomori S, Igarashi Y. Sphingosine-1- Phosphate: A platelet activating sphingolipid released from agonist-stimulated human platelets. Blood 1995; 86: 193- 202
  8. Rikitake Y, Kawashima S, Ozaki M, Takahashi T, Ogawa W, et al. Involvement of Endothelial Nitric oxide in Sphingosine- 1-Phosphate-Induced Angiogenesis. Arterioscler Thromb Vasc Biol 2002; 22: 108- 14
  9. Vollmer E, Brust J. Distribution patterns of apolipoproteins A I,AII, and B in the wall of atherosclerotic vessels. Virchows Archiv A pathol Anst 1991; 439: 79- 88
  10. Li XA, Guo L, Dressman JL, Asmis R, Smart EJ. A novel ligand-independent apoptotic pathway induced by scavenger receptor class B, type I and suppressed by endothelial nitricoxide synthase and high density lipoprotein. J Biol Chem 2005; 13; 280:19087- 96
  11. Bayhan G, Koçyigit Y, Atamer A, Atamer Y, Akkus Z. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia. Gynecol Endocrinol 2005; 21: 1- 6
  12. Demsey JC, Williams MA, leisenring WM, Shy K, Luthy DA. Maternal birth weight in relation to plasma lipid concentrations in early pregnancy. Am J Obstet Gynecol 2004; 190: 1359- 68
  13. Öztekin Ö, Can D, Adibelli Z, et al. The comparision of plasma lipid profiles of normal and hypertensive pregnancies in association with doppler findings. Ege T›p Dergisi 2003; 42: 183- 8
  14. Hla T. Sphingosine 1-Phosphate receptors. Prostoglandins Other Lipid Mediat 2001; 64: 135- 42
  15. Tolle M, Levkau B, Keul P et al. Immunomodulator FTY720 induces eNOS-dependent arterial vasodilata